APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Research

Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Research Report 2026

Report ID 174027340523 December 2025139 pages

Choose your research edition.

Industry ResearchPorcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine include China Animal Husbandry Co., Ltd., Yongshun Biological, Tiankang, Zoetis, Ruipu Biological, Qilu Animal Health, Pulike Biological, Jinyu and Sinopharm Animal Health, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market by Company

China Animal Husbandry Co., Ltd.

Yongshun Biological

Tiankang

Zoetis

Ruipu Biological

Qilu Animal Health

Pulike Biological

Jinyu

Sinopharm Animal Health

Dahuanong

Boehringer Ingelheim

Phibro Animal Health

MSD Animal Health

Komipharm

Ceva

CAVAC

Bioveta

Agrovet

Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Segment by Type

Live vaccines

Inactivated vaccines

Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Segment by Application

Government bidding

Market sales

Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (k units) of Manufacturers (2021-2026) Table 7. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Manufacturers (2021-2026) Table 8. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue of Manufacturers (2021-2026) Table 9. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Average Price (USD/unit) of Manufacturers (2021-2026) Table 11. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine, Product Type & Application Table 14. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. China Animal Husbandry Co., Ltd. Company Information Table 19. China Animal Husbandry Co., Ltd. Business Overview Table 20. China Animal Husbandry Co., Ltd. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 21. China Animal Husbandry Co., Ltd. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 22. China Animal Husbandry Co., Ltd. Recent Developments Table 23. Yongshun Biological Company Information Table 24. Yongshun Biological Business Overview Table 25. Yongshun Biological Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 26. Yongshun Biological Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 27. Yongshun Biological Recent Developments Table 28. Tiankang Company Information Table 29. Tiankang Business Overview Table 30. Tiankang Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 31. Tiankang Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 32. Tiankang Recent Developments Table 33. Zoetis Company Information Table 34. Zoetis Business Overview Table 35. Zoetis Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 36. Zoetis Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 37. Zoetis Recent Developments Table 38. Ruipu Biological Company Information Table 39. Ruipu Biological Business Overview Table 40. Ruipu Biological Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 41. Ruipu Biological Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 42. Ruipu Biological Recent Developments Table 43. Qilu Animal Health Company Information Table 44. Qilu Animal Health Business Overview Table 45. Qilu Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 46. Qilu Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 47. Qilu Animal Health Recent Developments Table 48. Pulike Biological Company Information Table 49. Pulike Biological Business Overview Table 50. Pulike Biological Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 51. Pulike Biological Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 52. Pulike Biological Recent Developments Table 53. Jinyu Company Information Table 54. Jinyu Business Overview Table 55. Jinyu Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 56. Jinyu Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 57. Jinyu Recent Developments Table 58. Sinopharm Animal Health Company Information Table 59. Sinopharm Animal Health Business Overview Table 60. Sinopharm Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 61. Sinopharm Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 62. Sinopharm Animal Health Recent Developments Table 63. Dahuanong Company Information Table 64. Dahuanong Business Overview Table 65. Dahuanong Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 66. Dahuanong Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 67. Dahuanong Recent Developments Table 68. Boehringer Ingelheim Company Information Table 69. Boehringer Ingelheim Business Overview Table 70. Boehringer Ingelheim Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 71. Boehringer Ingelheim Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 72. Boehringer Ingelheim Recent Developments Table 73. Phibro Animal Health Company Information Table 74. Phibro Animal Health Business Overview Table 75. Phibro Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 76. Phibro Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 77. Phibro Animal Health Recent Developments Table 78. MSD Animal Health Company Information Table 79. MSD Animal Health Business Overview Table 80. MSD Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 81. MSD Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 82. MSD Animal Health Recent Developments Table 83. Komipharm Company Information Table 84. Komipharm Business Overview Table 85. Komipharm Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 86. Komipharm Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 87. Komipharm Recent Developments Table 88. Ceva Company Information Table 89. Ceva Business Overview Table 90. Ceva Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. Ceva Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 92. Ceva Recent Developments Table 93. CAVAC Company Information Table 94. CAVAC Business Overview Table 95. CAVAC Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. CAVAC Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 97. CAVAC Recent Developments Table 98. Bioveta Company Information Table 99. Bioveta Business Overview Table 100. Bioveta Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Bioveta Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 102. Bioveta Recent Developments Table 103. Agrovet Company Information Table 104. Agrovet Business Overview Table 105. Agrovet Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. Agrovet Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 107. Agrovet Recent Developments Table 108. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 109. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region (2021-2026) & (k units) Table 110. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Region (2021-2026) Table 111. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region (2027-2032) & (k units) Table 112. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Region (2027-2032) Table 113. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 114. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Region (2021-2026) Table 115. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 116. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Region (2027-2032) Table 117. North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021-2026) & (k units) Table 119. North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2027-2032) & (k units) Table 120. North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 121. North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 122. Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021-2026) & (k units) Table 124. Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2027-2032) & (k units) Table 125. Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 126. Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 127. Asia Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. Asia Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021-2026) & (k units) Table 129. Asia Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2027-2032) & (k units) Table 130. Asia Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 131. Asia Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 132. South America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. South America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021-2026) & (k units) Table 134. South America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2027-2032) & (k units) Table 135. South America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 136. South America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 137. Middle East and Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 138. Middle East and Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021-2026) & (k units) Table 139. Middle East and Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2027-2032) & (k units) Table 140. Middle East and Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 141. Middle East and Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 142. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2021-2026) & (k units) Table 143. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2027-2032) & (k units) Table 144. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Type (2021-2026) Table 145. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Type (2027-2032) Table 146. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 147. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 148. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Type (2021-2026) Table 149. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Type (2027-2032) Table 150. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Type (2021-2026) & (USD/unit) Table 151. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Type (2027-2032) & (USD/unit) Table 152. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2021-2026) & (k units) Table 153. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2027-2032) & (k units) Table 154. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Application (2021-2026) Table 155. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Application (2027-2032) Table 156. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 157. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 158. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Application (2021-2026) Table 159. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Application (2027-2032) Table 160. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Application (2021-2026) & (USD/unit) Table 161. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Application (2027-2032) & (USD/unit) Table 162. Key Raw Materials Table 163. Raw Materials Key Suppliers Table 164. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Distributors List Table 165. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Customers List Table 166. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Trends Table 167. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Drivers Table 168. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Restraints Table 169. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Image Figure 5. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size (2021-2032) & (US$ Million) Figure 7. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (2021-2032) & (k units) Figure 8. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Average Price (USD/unit) & (2021-2032) Figure 9. Live vaccines Product Image Figure 10. Inactivated vaccines Product Image Figure 11. Government bidding Product Image Figure 12. Market sales Product Image Figure 13. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Share by Manufacturers in 2025 Figure 14. Global Manufacturers of Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine, Manufacturing Sites & Headquarters Figure 15. Global Top 5 and 10 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Players Market Share by Revenue in 2025 Figure 16. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 18. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region in 2025 Figure 19. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Region in 2025 Figure 20. North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country in 2025 Figure 21. North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Country (2021-2032) Figure 22. North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Country (2021-2032) Figure 23. United States Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 24. Canada Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Mexico Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country in 2025 Figure 27. Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Country (2021-2032) Figure 28. Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Country (2021-2032) Figure 29. Germany Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. France Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. U.K. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. Italy Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Russia Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Spain Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Netherlands Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Switzerland Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Sweden Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Poland Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Asia Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country in 2025 Figure 40. Asia Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Country (2021-2032) Figure 41. Asia Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Country (2021-2032) Figure 42. China Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Japan Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. South Korea Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. India Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Australia Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Taiwan Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Southeast Asia Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. South America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country in 2025 Figure 51. South America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Country (2021-2032) Figure 52. South America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Country (2021-2032) Figure 53. Brazil Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Argentina Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Chile Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Colombia Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Middle East and Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country in 2025 Figure 58. Middle East and Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Country (2021-2032) Figure 59. Middle East and Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Country (2021-2032) Figure 60. Egypt Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. South Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Israel Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Türkiye Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. GCC Countries Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Type (2021-2032) Figure 66. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Type (2021-2032) Figure 67. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price (USD/unit) by Type (2021-2032) Figure 68. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Application (2021-2032) Figure 69. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Application (2021-2032) Figure 70. Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price (USD/unit) by Application (2021-2032) Figure 71. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Value Chain Figure 72. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Opportunities and Challenges

Scope & coverage.

Types
  • Live vaccines
  • Inactivated vaccines
Applications
  • Government bidding
  • Market sales
Companies covered
  • China Animal Husbandry Co., Ltd.
  • Yongshun Biological
  • Tiankang
  • Zoetis
  • Ruipu Biological
  • Qilu Animal Health
  • Pulike Biological
  • Jinyu
  • Sinopharm Animal Health
  • Dahuanong
  • Boehringer Ingelheim
  • Phibro Animal Health
  • MSD Animal Health
  • Komipharm
  • Ceva
  • CAVAC
  • Bioveta
  • Agrovet

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size (2021-2032)
  4. 2.2.2 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (2021-2032)
  5. 2.2.3 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Average Price (2021-2032)
  6. 2.3 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Live vaccines
  9. 2.3.3 Inactivated vaccines
  10. 2.4 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Government bidding
  13. 2.4.3 Market sales
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (k units) of Manufacturers (2021-2026)
  3. 3.3 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine, Product Type & Application
  8. 3.8 Global Manufacturers of Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine, Established Date
  9. 3.9 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 China Animal Husbandry Co., Ltd.
  2. 4.1.1 China Animal Husbandry Co., Ltd. Company Information
  3. 4.1.2 China Animal Husbandry Co., Ltd. Business Overview
  4. 4.1.3 China Animal Husbandry Co., Ltd. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 China Animal Husbandry Co., Ltd. Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  6. 4.1.5 China Animal Husbandry Co., Ltd. Recent Developments
  7. 4.2 Yongshun Biological
  8. 4.2.1 Yongshun Biological Company Information
  9. 4.2.2 Yongshun Biological Business Overview
  10. 4.2.3 Yongshun Biological Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Yongshun Biological Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  12. 4.2.5 Yongshun Biological Recent Developments
  13. 4.3 Tiankang
  14. 4.3.1 Tiankang Company Information
  15. 4.3.2 Tiankang Business Overview
  16. 4.3.3 Tiankang Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Tiankang Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  18. 4.3.5 Tiankang Recent Developments
  19. 4.4 Zoetis
  20. 4.4.1 Zoetis Company Information
  21. 4.4.2 Zoetis Business Overview
  22. 4.4.3 Zoetis Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Zoetis Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  24. 4.4.5 Zoetis Recent Developments
  25. 4.5 Ruipu Biological
  26. 4.5.1 Ruipu Biological Company Information
  27. 4.5.2 Ruipu Biological Business Overview
  28. 4.5.3 Ruipu Biological Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Ruipu Biological Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  30. 4.5.5 Ruipu Biological Recent Developments
  31. 4.6 Qilu Animal Health
  32. 4.6.1 Qilu Animal Health Company Information
  33. 4.6.2 Qilu Animal Health Business Overview
  34. 4.6.3 Qilu Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Qilu Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  36. 4.6.5 Qilu Animal Health Recent Developments
  37. 4.7 Pulike Biological
  38. 4.7.1 Pulike Biological Company Information
  39. 4.7.2 Pulike Biological Business Overview
  40. 4.7.3 Pulike Biological Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Pulike Biological Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  42. 4.7.5 Pulike Biological Recent Developments
  43. 4.8 Jinyu
  44. 4.8.1 Jinyu Company Information
  45. 4.8.2 Jinyu Business Overview
  46. 4.8.3 Jinyu Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Jinyu Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  48. 4.8.5 Jinyu Recent Developments
  49. 4.9 Sinopharm Animal Health
  50. 4.9.1 Sinopharm Animal Health Company Information
  51. 4.9.2 Sinopharm Animal Health Business Overview
  52. 4.9.3 Sinopharm Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Sinopharm Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  54. 4.9.5 Sinopharm Animal Health Recent Developments
  55. 4.10 Dahuanong
  56. 4.10.1 Dahuanong Company Information
  57. 4.10.2 Dahuanong Business Overview
  58. 4.10.3 Dahuanong Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Dahuanong Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  60. 4.10.5 Dahuanong Recent Developments
  61. 4.11 Boehringer Ingelheim
  62. 4.11.1 Boehringer Ingelheim Company Information
  63. 4.11.2 Boehringer Ingelheim Business Overview
  64. 4.11.3 Boehringer Ingelheim Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Boehringer Ingelheim Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  66. 4.11.5 Boehringer Ingelheim Recent Developments
  67. 4.12 Phibro Animal Health
  68. 4.12.1 Phibro Animal Health Company Information
  69. 4.12.2 Phibro Animal Health Business Overview
  70. 4.12.3 Phibro Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Phibro Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  72. 4.12.5 Phibro Animal Health Recent Developments
  73. 4.13 MSD Animal Health
  74. 4.13.1 MSD Animal Health Company Information
  75. 4.13.2 MSD Animal Health Business Overview
  76. 4.13.3 MSD Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 MSD Animal Health Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  78. 4.13.5 MSD Animal Health Recent Developments
  79. 4.14 Komipharm
  80. 4.14.1 Komipharm Company Information
  81. 4.14.2 Komipharm Business Overview
  82. 4.14.3 Komipharm Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Komipharm Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  84. 4.14.5 Komipharm Recent Developments
  85. 4.15 Ceva
  86. 4.15.1 Ceva Company Information
  87. 4.15.2 Ceva Business Overview
  88. 4.15.3 Ceva Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Ceva Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  90. 4.15.5 Ceva Recent Developments
  91. 4.16 CAVAC
  92. 4.16.1 CAVAC Company Information
  93. 4.16.2 CAVAC Business Overview
  94. 4.16.3 CAVAC Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 CAVAC Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  96. 4.16.5 CAVAC Recent Developments
  97. 4.17 Bioveta
  98. 4.17.1 Bioveta Company Information
  99. 4.17.2 Bioveta Business Overview
  100. 4.17.3 Bioveta Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Bioveta Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  102. 4.17.5 Bioveta Recent Developments
  103. 4.18 Agrovet
  104. 4.18.1 Agrovet Company Information
  105. 4.18.2 Agrovet Business Overview
  106. 4.18.3 Agrovet Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 Agrovet Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  108. 4.18.5 Agrovet Recent Developments
5 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Scenario by Region
  1. 5.1 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region: 2021-2032
  3. 5.2.1 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region: 2021-2026
  4. 5.2.2 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region: 2027-2032
  5. 5.3 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Region: 2021-2032
  6. 5.3.1 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Region: 2021-2026
  7. 5.3.2 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Region: 2027-2032
  8. 5.4 North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Facts & Figures by Country
  9. 5.4.1 North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021-2032)
  11. 5.4.3 North America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Facts & Figures by Country
  16. 5.5.1 Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021-2032)
  18. 5.5.3 Europe Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Facts & Figures by Country
  41. 5.7.1 South America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021-2032)
  43. 5.7.3 South America Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.7.7 Colombia
  48. 5.8 Middle East and Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Facts & Figures by Country
  49. 5.8.1 Middle East and Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  50. 5.8.2 Middle East and Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021-2032)
  51. 5.8.3 Middle East and Africa Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Country (2021-2032)
  52. 5.8.4 Egypt
  53. 5.8.5 South Africa
  54. 5.8.6 Israel
  55. 5.8.7 Türkiye
  56. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2021-2032)
  2. 6.1.1 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2021-2032) & (k units)
  3. 6.1.2 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Type (2021-2032)
  4. 6.2 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type (2021-2032)
  5. 6.2.1 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2021-2032)
  2. 7.1.1 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2021-2032) & (k units)
  3. 7.1.2 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Application (2021-2032)
  4. 7.2 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Application (2021-2032)
  5. 7.2.1 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Value Chain Analysis
  2. 8.1.1 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Production Mode & Process
  5. 8.2 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Distributors
  8. 8.2.3 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Customers
9 Global Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Analyzing Market Dynamics
  1. 9.1 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Trends
  2. 9.2 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Drivers
  3. 9.3 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Opportunities and Challenges
  4. 9.4 Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research, Inc.
      Talk to an analyst